Wink D A, Vodovotz Y, Laval J, Laval F, Dewhirst M W, Mitchell J B
Radiation Biology Branch, National Cancer Institute, Bethesda, MD 20892, USA.
Carcinogenesis. 1998 May;19(5):711-21. doi: 10.1093/carcin/19.5.711.
The roles of nitric oxide (NO) in numerous disease states have generated considerable discussion over the past several years. NO has been labeled as the causative agent in different pathophysiological mechanisms, yet appears to protect against various chemical species such as those generated under oxidative stress. Similarly, NO appears to exert a dichotomy of effects within the multistage model of cancer. Chronic inflammation can lead to the production of chemical intermediates, among them NO, which in turn can mediate damage to DNA. Yet, NO also appears to be critical for the tumoricidal activity of the immune system. Furthermore, NO can also have a multitude of effects on other aspects of tumor biology, including angiogenesis and metastasis. This report will discuss how the chemistry of NO may impact the initiation and progression stages of cancer.
在过去几年中,一氧化氮(NO)在众多疾病状态下的作用引发了广泛的讨论。NO在不同的病理生理机制中被视为致病因素,但它似乎能抵御各种化学物质,比如在氧化应激下产生的那些物质。同样,在癌症的多阶段模型中,NO似乎也发挥着双重作用。慢性炎症会导致化学中间体的产生,其中包括NO,而NO反过来又可介导对DNA的损伤。然而,NO对于免疫系统的杀肿瘤活性似乎也至关重要。此外,NO对肿瘤生物学的其他方面,包括血管生成和转移,也可能产生多种影响。本报告将探讨NO的化学性质如何影响癌症的起始和进展阶段。